Related references
Note: Only part of the references are listed.Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer
Alejandra T. Perez et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Selective Control of Gene Expression by CDK9 in Human Cells
Judit Garriga et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
Min Li-Weber
CANCER TREATMENT REVIEWS (2009)
Mcl-1 is a potential therapeutic target in multiple types of cancer
C. Akgul
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Subchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid, in Beagle dogs
Jian Peng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Toxicological Studies of Wogonin in Experimental Animals
Qi Qi et al.
PHYTOTHERAPY RESEARCH (2009)
Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress
Chen Chen Jiang et al.
CANCER RESEARCH (2008)
Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases
Gaetano Romano et al.
CELL CYCLE (2008)
Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Gordon Shore et al.
CURRENT MOLECULAR MEDICINE (2008)
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation
Sonja Baumli et al.
EMBO JOURNAL (2008)
Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts
Heekyoung Chung et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines:: Mcl-1 inactivation
Min H. Kang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Real-time RT-PCR (TaqMan®) assays for the detection of viruses associated with Rugose wood complex of grapevine
Fatima Osman et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Anti-carcinogenic Effects of the Flavonoid Luteolin
Guenter Seelinger et al.
MOLECULES (2008)
Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2
Na Lu et al.
LIFE SCIENCES (2008)
Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa
Ai-Lin Liu et al.
PLANTA MEDICA (2008)
Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology
Shudong Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells
Henning Schulze-Bergkamen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis
Sven Baumann et al.
BLOOD (2008)
Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7
Rob D. Chapman et al.
SCIENCE (2007)
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer
Hope Rugo et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Anti-hepatitis B virus activity of wogonin in vitro and in vivo
Qinglong Guo et al.
ANTIVIRAL RESEARCH (2007)
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: Down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
Syed-Rehan A. Hussain et al.
CLINICAL CANCER RESEARCH (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Mechanism and functional role of XIAP and McI-1 down-regulation in flavopiridol/vorinostat antileukemic interactions
Roberto R. Rosato et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis
Stefanie C. Fas et al.
BLOOD (2006)
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction
Henning Schulze-Bergkamen et al.
BMC CANCER (2006)
Mitochondria as therapeutic targets for cancer chemotherapy
L. Galluzzi et al.
ONCOGENE (2006)
The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo
Wei Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
HTLV-1 tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)
Andreas Krueger et al.
BLOOD (2006)
Cyclin-dependent kinase pathways as targets for cancer treatment
GI Shapiro
JOURNAL OF CLINICAL ONCOLOGY (2006)
The multiple common point set problem and its application to molecule binding pattern detection
M Shatsky et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2006)
Elongation by RNA polymerase II: the short and long of it
RJ Sim et al.
GENES & DEVELOPMENT (2004)
Unraveling hot spots in binding interfaces: progress and challenges
WL DeLano
CURRENT OPINION IN STRUCTURAL BIOLOGY (2002)
Share Paper
